Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
Active, not recruiting · NCT05575037 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease | Asthma, Aspirin-Induced, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, drug allergy, immune system disorder, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, polyp, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-08-13 | NCT05575037 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |